Association between inflammatory mediators and angiographic morphologic features indicating thrombus formation in patients with acute myocardial infarction

Chinese Medical Journal

Volumn 122, Issue 15, 2009, Pages 1738-1742

  Li, Dong Bao ^a   Hua, Qi ^a   Liu, Zhi ^a   Li, Jing ^a   Xu, Li Qing ^a   Wang, Shan ^a   Jin, Wei Ying ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Acute myocardial infarction; C reactive protein; Neutrophil; Percutaneous coronary intervention; Thrombosis

Indexed keywords

C REACTIVE PROTEIN;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY THROMBOSIS; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; MORTALITY; NEUTROPHIL COUNT; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROGNOSIS; RIGHT CORONARY ARTERY; ST SEGMENT ELEVATION; THROMBOGENESIS;

AGED; C-REACTIVE PROTEIN; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 70349559362     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.15.004     Document Type: Article

References (28)

1. Barron HV, Harr SD, Radfort MJ, Wang Y, Krumholz HM. The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol 2001; 38: 1654-1661.
2. Cusack MR, Marber MS, Lambiase PD, Bucknall CA, Redwood SR. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol 2002; 39: 1917-1923.
3. Youssef AA, Chang LT, Sheu JJ, Lee FY, Chua S, Yeh KH, et al. Association between circulating level of CD40 ligand and angiographic morphologic features indicating high-burden thrombus formation in patients with acute myocardial infarction undergoing primary coronary. Circ J 2007; 71: 1857-1861.
4. Verma S, Li SH, Badiwala MV, Weisel RD, Fedak PW, Li RK, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002; 105: 1890-1896.
5. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-1818.
6. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson, CM. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation 2000; 102: 2329-2334.
7. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, et al. Which white blood cells subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005; 45: 1638-1643.
8. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long term mortality after percutaneous coronary intervention. Am J Cardiol 2006; 97: 993-996.
9. Burke AP, Tracy RP, Kologie F, Malcom GT, Zieske A, Butys R, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002; 105: 2019-2023.
10. Yip HK, Chen MC, Chang HW, Hang CL, Hsieh YK, Fang CY, et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow flow and no-reflow. Chest 2002; 122: 1322-1332.
11. Tanaka A, Kawarabayashi T, Nishibori Y, Sano T, Nishida Y, Fukuda D, et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation 2002; 105: 2148-2152.
12. Yip HK, Wu CJ, Chang HW, Chen MC, Hang CL, Fang CY, et al. Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and evaluation of prognostic determinants. Am J Cardiol 2001; 87: 1184-1188.
13. Hoshiba Y, Hatakeyama K, Tanabe T, Asada Y, Goto S. Co-localization of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction. J Thromb Haemost 2006; 4: 114-120.
14. Menon V, Lessard D, Yarzbski J, Furman MI, Gore JM, Goldberg RJ. Leukocytosis and adverse hospital outcomes after acute myocardial infarction. Am J Cardiol 2003; 92: 368-372.
15. Sweetnam P, Thomas H, Yarnell J, Baker I, Elwood P. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol 1997; 145: 416-421.
16. Huang ZC, Chien KL, Yang CY, Wang CH, Chang T, Chen CJ. Peripheral differential leukocyte counts and subsequent mortality for all diseases, cancers, and cardiovascular diseases in Taiwanese. J Formos Med Assoc 2003; 102: 775-781.
17. Kawaguchi H, Mori T, Kawano T, Kono S, Sasaki J, Arakawa K. Band neutrophil count and the presence and severity of coronary atherosclerosis. Am Heart J 1996; 132 (1 Pt 1): 9-12.
18. Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002; 106: 2894-2900.
19. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by p-selectin on adherent platelets. Nature 1992; 359: 848-851.
20. Zazula AD, Précoma-Neto D, Gomes AM, Kruklis H, Barbieri GF, Forte RY, et al. An assessment of neutrophils/lymphocytes ratio in patients suspected of acute coronary syndrome. Arq Bras Cardiol 2008; 90: 30-35.
21. Shah PK. Circulating markers of inflammation for vascular risk prediction: are they ready for prime time? Circulation 2000; 101: 1758-1759.
22. Mueller C, Buettner HJ, Hodgson JM, Marsch S, Perruchoud AP, Roskamm H, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 2002; 105: 1412-1415.
23. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565.
24. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 2000; 343: 1139-1147.
25. Kaul U, Singh B, Sudan D, Sapra R, Yadav RD, Ghose T, et al. Primary stenting in acute myocardial infarction: a 30-day follow up study. Catheter Cardiovasc Interv 1999; 46: 4-10.
26. Kern MJ, Moore JA, Aguirre FV, Bach RG, Garacciolo EA, Wolford T, et al. Determination of angiographic (TIMI grade) blood flow by intracoronary doppler flow velocity during acute myocardial infarction. Circulation 1996; 94: 1545-1552.
27. Zhang XW, Ge JB, Yang JM, Ge L, Wang NF, Gao Y, et al. Relationship between hs-CRP, proMMP-1, TIMP-1 and coronary plaque morphology: intravascular ultrasound study. Chin Med J 2006; 119: 1689-1694.
28. Fu XH, Fan WZ, Gu XS, Wei YY, Jiang YF, Wu WL, et al. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction. Chin Med J 2007; 120: 1226-1231.